Want to see AU:DVL full AI Analyst Report?
Top Page
dorsaVi Limited
(Sydney:DVL)
Select Model
Select Model
Rating:38Underperform
Price Target:
AU$0.02
▼(-20.00% Downside)
Action:Downgraded
Date:07/15/26
The score is pressured primarily by weak financial performance (declining revenue, ongoing losses, and negative operating/free cash flow). Technicals also detract as the stock trades below all major moving averages with negative MACD, indicating a bearish trend. Valuation provides limited support because the company is loss-making (negative P/E) and no dividend yield data is available.
Positive Factors
Niche wearable sensor product
dorsaVi’s integrated wearable sensor hardware and software serve clinical assessment, rehabilitation and workplace health. That focused product-market fit creates durable differentiation and sticky workflows with professionals, supporting steady demand and deeper clinical adoption over months.
Negative Factors
Declining revenue trend
A multiyear decline in revenue reduces scale benefits, weakens commercial leverage, and lengthens the path to breakeven. Persistently falling top line undermines ability to absorb fixed costs, constrains reinvestment in sales and product, and increases reliance on external funding.
Read all positive and negative factors
Positive Factors
Negative Factors
Niche wearable sensor product
dorsaVi’s integrated wearable sensor hardware and software serve clinical assessment, rehabilitation and workplace health. That focused product-market fit creates durable differentiation and sticky workflows with professionals, supporting steady demand and deeper clinical adoption over months.
Read all positive factors
dorsaVi Limited (DVL) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$28.41M
Dividend YieldN/A
Average Volume (3M)8.34M
Price to Earnings (P/E)―
Beta (1Y)1.70
Revenue Growth-25.87%
EPS Growth-150.00%
CountryAU
Employees34
SectorTechnology
Sector Strength88
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,235,028,400
10 Day Avg. Volume5,304,106
30 Day Avg. Volume8,343,384
Financial Highlights & Ratios
PEG Ratio1.57
Price to Book (P/B)3.65
Price to Sales (P/S)9.17
P/FCF Ratio-10.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
dorsaVi Limited Business Overview & Revenue Model
Company Description
dorsaVi Ltd, an Australian company established in 2008 and based in Oakleigh South, focuses on creating and distributing advanced motion analysis technologies throughout Australia, Europe, and the United States. Its product portfolio includes ViMo...
How the Company Makes Money
null...
dorsaVi Limited Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
45
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 999.29K | 1.13M | 1.30M | 1.75M | 2.35M | 1.87M |
| Gross Profit | -1.75M | 971.82K | 1.18M | -798.43K | -1.45M | -1.74M |
| EBITDA | -4.87M | -1.82M | -1.60M | -1.88M | -1.53M | -2.29M |
| Net Income | -4.53M | -1.52M | -1.25M | -1.82M | -1.54M | -2.41M |
Balance Sheet | ||||||
| Total Assets | 8.13M | 3.97M | 2.18M | 2.69M | 3.36M | 5.42M |
| Cash, Cash Equivalents and Short-Term Investments | 4.95M | 2.29M | 478.10K | 878.72K | 449.70K | 2.80M |
| Total Debt | 135.68K | 156.89K | 190.17K | 321.85K | 1.18M | 1.18M |
| Total Liabilities | 2.15M | 1.14M | 1.16M | 1.01M | 2.13M | 2.95M |
| Stockholders Equity | 5.99M | 2.84M | 1.02M | 1.68M | 1.22M | 2.48M |
Cash Flow | ||||||
| Free Cash Flow | -2.68M | -956.83K | -622.08K | -1.02M | -2.25M | -2.36M |
| Operating Cash Flow | -2.68M | -956.83K | -600.90K | -967.41K | -2.15M | -2.27M |
| Investing Cash Flow | -299.61K | -304.00K | -21.18K | -51.65K | -100.34K | -85.41K |
| Financing Cash Flow | 6.72M | 3.08M | 227.06K | 1.45M | -92.25K | 3.47M |
dorsaVi Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | AU$1.12B | -18.13 | -15.51% | ― | 19.02% | -140.54% | |
42 Neutral | AU$78.29M | -6.16 | -76.07% | ― | ― | ― | |
41 Neutral | AU$56.72M | -3.58 | -60.02% | ― | 15.14% | -102.70% | |
41 Neutral | AU$5.79M | -5.93 | -92.37% | ― | 17.44% | 61.64% | |
41 Neutral | AU$3.89M | -0.08 | 209.30% | ― | -13.81% | -37.77% | |
38 Underperform | AU$28.41M | -4.89 | -102.57% | ― | -25.87% | -150.00% |
* Technology Sector Average
AU:DVL
dorsaVi Limited
0.02
-0.02
-50.00%
AU:CAT
Catapult Group International
3.73
-2.34
-38.55%
AU:X2M
X2M Connect Limited
0.01
0.00
0.00%
AU:VR1
Vection Technologies Ltd.
0.02
-0.03
-52.94%
AU:AUA
Audeara Ltd.
0.03
<0.01
6.67%
AU:NVU
Nanoveu Ltd.
0.07
-0.03
-28.87%
dorsaVi Limited Corporate Events
DorsaVi Advances Edge-AI Hardware Program for Robotics and Exoskeletons
Jul 29, 2026
DorsaVi reported a highly active June quarter as it advanced its RRAM and neuromorphic technology program for robotics and exoskeleton edge computing. The company highlighted its focus on overcoming the “memory wall” in edge devices by...
DorsaVi Launches Physical AI Sensor v6.5 for On-Device Movement Intelligence
Jul 27, 2026
DorsaVi Limited has launched Sensor v6.5, an intelligent wearable that processes human movement and delivers biofeedback directly on the device in real time, without reliance on an iPad, PC or cloud connection. Built on the company’s existin...
dorsaVi Moves 22-nm RRAM Program Into Tape-Out and Silicon Validation
Jul 14, 2026
dorsaVi Limited has begun the tape-out process for its first 22-nanometre RRAM-CMOS validation chip in collaboration with tier-one semiconductor partners, moving the project from design finalisation into physical silicon manufacturing using commer...
DorsaVi Options Lapse, Clarifying Issued Capital Structure
Jul 14, 2026
DorsaVi Ltd has notified the market of the cessation of a series of options, designated DVLAA, that expired without being exercised or converted on 5 July 2026 and 8 April 2026, respectively. The lapse of these 3,076,247 options reduces the pool o...
DorsaVi completes RRAM-CMOS validation chip design and moves to fabrication
Jun 17, 2026
DorsaVi has completed the full design package for its first integrated RRAM-CMOS validation chip, developed with partners NTU Singapore and ITRI Taiwan, and is now moving the program into tape-out and staged silicon implementation. The design is i...
dorsaVi plans 5 million-share placement on ASX
Jun 9, 2026
dorsaVi Ltd has announced a proposed placement of up to 5,000,000 ordinary fully paid shares, as disclosed in an Appendix 3B filing with the ASX. The securities are expected to be issued on 30 July 2026, subject to ASX processes, and form part of ...
DorsaVi Targets Exoskeleton Intelligence Layer With In-Sensor Computing Push
Jun 3, 2026
DorsaVi has completed a strategic analysis showing that integrating its EMG and movement sensors with resistive random-access memory and neuromorphic in-sensor computing could sharply reduce sensor counts and data loads in exoskeletons, while more...
dorsaVi Proves High-Temperature Reliability of RRAM Memory for Harsh Environments
May 31, 2026
dorsaVi has reported that its RRAM cells maintained predictable and fully reversible performance at operating temperatures up to 150°C, aligning with stringent AEC-Q100 automotive-grade reliability standards. The tests showed that temperature...
dorsaVi Extends U.S. Defense-Funded Sensor Study to Cut Military Training Injuries
May 10, 2026
dorsaVi Limited has renewed its research contract with Georgia Southern University, funded by the U.S. Department of Defense, to deploy its wearable sensors in field-based military training to address stress fractures among trainees. The study ext...
dorsaVi Moves to Manufacturable Ultra-Edge Hardware with Modular Platform Program
May 6, 2026
dorsaVi has launched its Ultra-Edge Modular Design and Build program, a key stage in its five-step execution roadmap that will turn its validated RRAM semiconductor and neuromorphic computing IP into a manufacturable hardware platform. The effort ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.